CNS Spectrums

Papers
(The median citation count of CNS Spectrums is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Urbanization and emerging mental health issues87
Environmental pollution and mental health: a narrative review of literature50
Substance-related exogenous psychosis: a postmodern syndrome50
A framework for understanding the pathophysiology of functional neurological disorder47
Impact of economic crisis on mental health: a 10-year challenge27
Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis26
Eating disorders and autism spectrum: links and risks25
Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia24
A brief history of the criminalization of mental illness23
Insomnia, sleep loss, and circadian sleep disturbances in mood disorders: a pathway toward neurodegeneration and neuroprogression? A theoretical review22
Mental health consequences for survivors of the 2011 Fukushima nuclear disaster: a systematic review. Part 1: psychological consequences21
Stigma and functional neurological disorder: a research agenda targeting the clinical encounter21
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice18
Treatment of functional neurological disorder: current state, future directions, and a research agenda18
A pathway phenotype linking metabolic, immune, oxidative, and opioid pathways with comorbid depression, atherosclerosis, and unstable angina18
Defining effective strategies to prevent post-traumatic stress in healthcare emergency workers facing the COVID-19 pandemic in Italy17
Camouflaging: psychopathological meanings and clinical relevance in autism spectrum conditions17
Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis17
Long-acting injectable antipsychotics: what, when, and how17
Novel antidepressant drugs: Beyond monoamine targets16
Sex differences in patients with Tourette syndrome16
Investigating the relationship between orthorexia nervosa and autistic traits in a university population15
In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life15
Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial14
Mental health consequences for survivors of the 2011 Fukushima nuclear disaster: a systematic review. Part 2: emotional and behavioral consequences14
Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocation14
The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression13
Fixated Threat Assessment Centers: preventing harm and facilitating care in public figure threat cases and those thought to be at risk of lone-actor grievance-fueled violence13
Post-traumatic stress symptoms in an Italian cohort of subjects complaining occupational stress13
What misdiagnoses do women with autism spectrum disorder receive in the DSM-5?12
Toward a transdiagnostic neurocircuitry-based biomarker model for pro-cognitive effects: challenges, opportunities, and next steps12
Safety and Effectiveness of SEP−363856 in Schizophrenia: Results of a 6-Month, Open-Label Extension Study11
The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia11
Kynurenine pathway and autism spectrum phenotypes: an investigation among adults with autism spectrum disorder and their first-degree relatives11
Long-term safety and durability of effect with a combination of olanzapine and samidorphan in patients with schizophrenia: results from a 1-year open-label extension study11
Early onset obsessive–compulsive disorder: the biological and clinical phenotype10
Autistic traits and camouflaging behaviors: a cross-sectional investigation in a University student population10
Role of obesity in systemic low-grade inflammation and cognitive function in patients with bipolar I disorder or major depressive disorder10
Autism spectrum in patients with schizophrenia: correlations with real-life functioning, resilience, and coping styles10
Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment10
General impulsivity in binge-eating disorder10
Diagnosing functional neurological disorder: seeing the whole picture10
Do somatic symptoms relate to PTSD and gender after earthquake exposure? A cross-sectional study on young adult survivors in Italy9
Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan Disability Scale in patients with major depressive disorder: a systematic review and 9
Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression9
Early response to trazodone once-a-day in major depressive disorder: review of the clinical data and putative mechanism for faster onset of action8
An innovative approach to the assessment of mood disturbances in patients with acute coronary syndrome8
Schizotypal personality disorder in clinical obsessive–compulsive disorder samples: a brief overview8
Cocaine use in university students: relationships with demographics, mental health, risky sexual practices, and trait impulsivity8
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study8
Munchausen syndrome by proxy (MSBP): a review regarding perpetrators of factitious disorder imposed on another (FDIA)8
Current and future nonstimulants in the treatment of pediatric ADHD: monoamine reuptake inhibitors, receptor modulators, and multimodal agents8
The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women8
Precision and personalized assessment, diagnosis and treatment in psychiatry8
How concerned should we be about neurotropism of SARS-Cov-2? A brief clinical consideration of the possible psychiatric implications8
Neurological manifestations in coronavirus disease 2019 (COVID-19) patients: a systematic review of literature8
Identifying functional cognitive disorder: a proposed diagnostic risk model8
Space missions: psychological and psychopathological issues8
Dementia-related psychosis and the potential role for pimavanserin7
Outcome in depression (I): why symptomatic remission is not good enough7
Montreal cognitive assessment for evaluating cognitive impairment in Huntington’s disease: a systematic review7
Exploring the role of serum lipid profile and neutrophil-to-lymphocyte ratio in violent suicide attempters: a cross sectional study7
Using classification and regression tree modeling to investigate appetite hormones and proinflammatory cytokines as biomarkers to differentiate bipolar I depression from major depressive disorder7
Motor activity patterns can distinguish between interepisode bipolar disorder patients and healthy controls7
Brain-derived neurotrophic factor among patients with alcoholism7
Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials7
Inflammatory cytokines in and cognitive function of adolescents with first-episode schizophrenia, bipolar disorder, or major depressive disorder7
Effect of vortioxetine in subjects with major depressive and alcohol use disorders: a 6-month retrospective analysis7
The frequency and framing of cognitive lapses in healthy adults6
Parasomnias in patients with addictions—a systematic review6
Mental illness among 500 people living homeless and referred for psychiatric evaluation in Lisbon, Portugal6
Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy6
Decriminalizing LGBTQ+: Reproducing and resisting mental health inequities6
113 Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P303) Assessing Efficacy and Safety of Extended-Release Viloxazine in Children with ADHD6
The relationship between depression with anxious distress DSM-5 specifier and mixed depression: a network analysis6
Decreased vitamin D levels in obsessive-compulsive disorder patients6
A randomized clinical trial to assess the efficacy of trial-based cognitive therapy compared to prolonged exposure for post-traumatic stress disorder: preliminary findings6
Response to: Eculizumab package insert recommendations for meningococcal vaccinations: call for clarity and a targeted approach for use of the drug in neuromyelitis optica spectrum disorder6
Obsessive–compulsive disorder—contamination fears, features, and treatment: novel smartphone therapies in light of global mental health and pandemics (COVID-19)6
The neurobiology of obsessive–compulsive personality disorder: a systematic review6
Effects of Cariprazine on Cognition in Patients With Bipolar Mania or Mixed States: Post Hoc Analysis From 3 Randomized, Controlled Phase III Studies6
When neurologists diagnose functional neurological disorder, why don’t they code for it?6
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation6
Intelligence decline across major depressive disorder, bipolar disorder, and schizophrenia6
A 6-month follow-up study on response and relapse rates following an acute trial of repetitive transcranial magnetic stimulation in patients with major depression6
The place of obsessive–compulsive and related disorders in the compulsive–impulsive spectrum: a cluster-analytic study6
Climate shift and mental health adjustment6
Adjunctive treatment with psychostimulants and stimulant-like drugs for resistant bipolar depression: a systematic review and meta-analysis6
Along the fringes of Agency: neurodevelopmental account of the obsessive mind6
The shocking attitude toward electroconvulsive therapy in Italy5
Suicidal ideation and suicidal attempts in patients with obsessive-compulsive tic-related disorder vs obsessive-compulsive disorder: results of a multicenter Italian study5
The complex interactions among serotonin, insulin, leptin, and glycolipid metabolic parameters in human obesity5
Suicidality and self-injurious behavior among adolescent social media users at psychiatric hospitalization5
Digital health technologies and major depressive disorder5
Jail diversion: the Miami model5
160 Lurasidone and Metabolic Syndrome: Results from Short- and Long-Term Clinical Studies in Patients with Bipolar Depression5
Duration of untreated autism in rural America: emerging public health crisis5
Bipolar Spectrum disorders in Parkinson’s disease: a systematic evaluation5
The increasing challenge of the possible impact of ethnicity on psychopharmacology5
Pharmacologic interventions for antidepressant-induced sexual dysfunction: a systematic review and network meta-analysis of trials using the Arizona sexual experience scale5
Mental pain and pain-proneness in patients with migraine: results from the PAINMIG cohort-study5
Trichotillomania—psychopathological correlates and associations with health-related quality of life in a large sample5
Binge-eating disorder in university students: high prevalence and strong link to impulsive and compulsive traits5
Behavioral measures of impulsivity and compulsivity in adolescents with nonsuicidal self-injury5
Modeling psychological function in patients with schizophrenia with the PANSS: an international multi-center study5
The long-acting injectable atypical antipsychotics—merits and demerits!5
The motor profile of obsessive-compulsive rituals: psychopathological and evolutionary implications5
Altered dynamic interactions within frontostriatal circuits reflect disturbed craving processing in internet gaming disorder5
Deconstructing violence in acutely exacerbating psychotic patients5
127 Successful Treatment of Major Depressive Disorder with Moclobemide After Recurrent Hyponatremia Induced by Multiple Antidepressant Classes5
Safety and efficacy of KarXT (Xanomeline Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial5
Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical rev5
Effects of the number of hospitalizations on cognitive function in Japanese patients with stable schizophrenia4
Substance Use Trajectories: Nonmedical Use (NMU) of Prescription Stimulants via Non-Oral Routes of Administration Among Adults Recruited from Reddit4
Is treatment-resistant schizophrenia associated with distinct neurobiological callosal connectivity abnormalities?4
Electroconvulsive therapy: still the gold standard for highly treatment-resistant mood disorders4
138 Efficacy and Safety of SEP-363856, a Novel Psychotropic Agent with a Non-D2 Mechanism of Action, in the Treatment of Schizophrenia4
The influence of prescriber and patient gender on the prescription of benzodiazepines: results from the Florida Medicaid Dataset4
Aripiprazole Lauroxil Dosing Regimens: Understanding Dosage Strengths and Injection Intervals4
From trauma-blind to trauma-informed: re-thinking criminalization and the role of trauma in persons with serious mental illness4
Outcome in depression (II): beyond the Hamilton Depression Rating Scale4
Treatment strategies for clozapine-induced nocturnal enuresis and urinary incontinence: a systematic review4
Statistical predictors of psychosocial impairment in body-focused repetitive behaviors4
Migraine: interactions between brain’s trait and state4
Treatment of refractory obsessive–compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study4
Absconsion in forensic psychiatric services: a systematic review of literature4
Exploring the clinical profile of problematic pornography use4
A social history of serious mental illness4
The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophrenia4
Assessing the educational needs of physicians in the management of patients with Tourette syndrome: results of a United States survey on practicing clinicians and caregivers4
From checking the door to checking the app: assessment and treatment implications for obsessive–compulsive disorder in the digital era4
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia4
Dopamine D3 partial agonists in the treatment of psychosis and substance use disorder comorbidity: a pharmacological alternative to consider?4
Lumateperone (ITI−007) in the Treatment of Bipolar Depression: Results from a Randomized Clinical Trial3
Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia3
Compulsive buying behavior of Smartphones by university students3
Plasma redox and inflammatory patterns during major depressive episodes: a cross-sectional investigation in elderly patients with mood disorders3
147 Training Forgiveness. A Novel Approach to Reducing Physician Burnout3
Long-acting injectable antipsychotics: what, when, and how – Addendum3
Psychopathy in women: insights from neuroscience and ways forward for research3
Bupropion—myth-busting!3
A Phase 2a Double-Blind Randomized Trial of REL-1017 (Esmethadone) in Patients with MDD: Analysis of Subscales from the Symptoms of Depression Questionnaire3
Improvement in Anxiety Symptoms in Depressed Patients Treated With AXS-05 (DEXTROMETHORPHAN-BUPROPION): Results From the Evolve Open-Label, Long-Term Study3
Professional attitudes toward the use of neuromodulatory technologies in Mexico: Insight for neuroethical considerations of cultural diversity3
Neural circuits of anxiolytic and antidepressant pherine molecules3
Is there a relationship between morphological and functional platelet changes and depressive disorder?3
152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents3
Chronotype is differentially associated with lifetime mood and panic-agoraphobic spectrum symptoms in patients with bipolar disorder and healthy controls3
A scoping review on paraneoplastic autoimmune limbic encephalitis (PALE) psychiatric manifestations3
Safety and efficacy of early augmentation with repetitive transcranial magnetic stimulation in the treatment of drug-free patients with obsessive–compulsive disorder3
A difficult case of satyriasis in an adolescent responding ultimately to a combination of paliperidone palmitate and naltrexone3
Autistic traits in young adults who gamble3
Long-acting injectable antipsychotics: what, when, and how – CORRIGENDUM3
Correlations between peripheral levels of inflammatory mediators and frontolimbic structures in bipolar disorder: an exploratory analysis3
Proinflammatory biomarkers are associated with prediabetes in patients with schizophrenia3
Psychopathology in refugees subjected to the Dublin Regulation: an Italian study3
Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence3
Do antibullying laws in the United States have an impact?3
184 Insulin Sensitivity and Glucose Metabolism of Olanzapine and Combination Olanzapine and Samidorphan: A Phase 1 Exploratory Study in Healthy Volunteers2
Genome-wide DNA methylation profiling in nonagenarians suggests an effect of PM20D1 in late onset Alzheimer’s disease2
166 Post Market Rate of Seizures During TMS Treatment with NeuroStar® System Appears to Be Lower than Previously Estimated2
Successful agomelatine monotherapy for an adolescent with attention deficit hyperactivity disorder and comorbid migraine2
Pharmacologic predictors of benzodiazepine response trajectory in anxiety disorders: a Bayesian hierarchical modeling meta-analysis2
Unmet needs of mental illness issues in COVID-19: the importance of analyzing neuropsychiatric manifestations2
Anticholinergics Should Not Be Used to Treat Tardive Dyskinesia: Insights From an Expert Panel of Psychiatry and Neurology Healthcare Professionals2
Is this Withdrawal or Intoxication? Case Report Regarding Complications of Unregulated Use of Tianeptine, Etizolam, and Phenibut in the USA2
Exploring suicidality in the aftermath of the 2022 flood in Pakistan: insights from newspaper reports2
Discovering Non-Invasive Biomarkers Predictive of Opioid Use Disorder Treatment Response2
Application of a staging model in patients with obsessive–compulsive disorder: cross-sectional and follow-up results2
Cognitive impairment in hoarding disorder: a systematic review2
Adjunctive neuronavigated accelerated continuous theta-burst stimulation in obsessive-compulsive disorder: a randomized sham-controlled study2
Disruptive mood dysregulation disorder: does variance in treatment responses also add to the conundrum? The widening gap in the evidence is a signal needing attention2
Bipolar spectrum disorder masquerading as treatment resistant unipolar depression2
Duration of untreated illness in gambling disorder2
Peripheral insulin sensitivity predicting cognitive function in euthymic bipolar disorder patients2
Psychoendocrinology: arginine vasopressin and resilience in patients with major depressive disorder2
Brain activation alterations with adjunctive deep transcranial magnetic stimulation in obsessive-compulsive disorder: an fMRI study2
Gender, age at onset, and duration of being ill as predictors for the long-term course and outcome of schizophrenia: an international multicenter study2
141 Moderating Perspectives of Long Acting Injectable Use of Antipsychotics: A Literature Review2
A pilot study on the association between the blood oxygen level-dependent signal in the reward system and dopamine transporter availability in adults with attention deficit hyperactivity disorder2
Poor man’s vortioxetine2
Overcoming the Challenges of the Mental Health Care System in United States in the Aftermath of COVID-192
114 An Assessment of QTc Effects With SPN-812 (Extended-Release Viloxazine) in Healthy Adults2
Zuranolone, a Positive Allosteric Modulator of the GABAA Receptor: Hypothesized Mechanism of Action in Major Depressive Disorder2
Understanding Why Muscarinic Receptor Agonists Have Antipsychotic Properties2
The Economic Burden of Schizophrenia in the United States in 20192
190 Treating Fibromyalgia Syndrome through Neuromodulation With Transcranial Magnetic Stimulation2
The role of the metabotropic glutamate receptor 5 in nicotine addiction2
191 Lamotrigine Overdose with urine Toxicology Positive for Phencyclidine: A Case Report of Possible Cross-Reactivity2
TeleSCOPE: A Real-World Study of Telehealth for the Detection and Treatment of Drug-Induced Movement Disorders2
A long-term, open-label study of valbenazine for tardive dyskinesia2
Diagnosing and treating major depressive episodes that lie along the mood disorders spectrum: focus on depression with mixed features2
Pharmacological interventions to reduce violence in patients with schizophrenia in forensic psychiatry2
IL-6, homocysteine, and autism spectrum phenotypes: an investigation among adults with autism spectrum disorder and their first-degree relatives2
Quantifying Psychopathology in Rapid Readmissions2
Metabolic Syndrome in Bipolar Depression with Lumateperone (ITI-007): A Post Hoc Analysis of 2 Randomized, Placebo-Controlled Trials2
Decriminalizing severe mental illness by reducing risk of contact with the criminal justice system, including for forensic patients2
Real-world effectiveness of long-acting injectable antipsychotics to reduce 90-day and annual readmission in psychotic disorders: insights from a state psychiatric hospital2
Phase 3 Safety and Tolerability Results of the Combination Olanzapine and Samidorphan in Patients with Schizophrenia: The 1 Year ENLIGHTEN-2-Extension2
N-acetyl-cysteine in schizophrenia—there is more than meets the eyes!2
Galantamine beyond Alzheimer’s disease—a fact or artefact?2
The Challenge of Managing Patients Suffering from TBI: The Utility of Multiparametric MRI2
Hydrocortisone in the emergency department: a prospective, double-blind, randomized, controlled posttraumatic stress disorder study. Hydrocortisone during golden hours2
Divergence of dose–response with asenapine: a cluster analysis of randomized, double-blind, and placebo control study2
186 Results From a 12-Month Open-label Safety Study of Lumateperone (ITI-007) in Patients with Stable Symptoms of Schizophrenia2
The Utility of Planned Deprescribing in Pandemics and Other Disasters: A Systematic Review2
Post-traumatic stress disorder in train crash survivors in Italy: the role of mood spectrum dysregulations and intrusiveness2
Using event-related potentials to characterize inhibitory control and self-monitoring across impulsive and compulsive phenotypes: a dimensional approach to OCD2
Opioid antagonism mitigates antipsychotic-associated weight gain: focus on olanzapine2
135 Evolution of a Study of Bilateral Prefrontal Transcranial Magnetic Stimulation (TMS) to Treat the Symptoms of Mild TBI (mTBI) and PTSD2
112 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (P302): Efficacy and Safety of Extended-Release Viloxazine in Adolescents with ADHD2
Length of stay for inpatient incompetent to stand trial patients: importance of clinical and demographic variables2
Potential advantages of ketamine over electroconvulsive therapy in the treatment of nonrefractory severe depression in older patients with multiple medical comorbidities2
Comparison of executive dysfunction, proinflammatory cytokines, and appetite hormones between first-episode and multiple-episode bipolar disorders2
185 The Safety and Tolerability of Lumateperone 42 mg for the Treatment of Schizophrenia: A Pooled Analysis of 3 Randomized Placebo-Controlled Trials2
Head circumference in infants with nonopiate-induced neonatal abstinence syndrome2
Sports psychiatry: a desideratum on sports arena!2
Reward functioning from an attentional perspective and obsessive-compulsive symptoms—an eye-tracking study2
Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington’s Disease: Results From the ARC-HD Open-label Study2
Efficacy of Lurasidone in Antipsychotic-Naive vs. Antipsychotic-Exposed Adolescents with Schizophrenia: Post-Hoc Analysis of a Two-Year, Open-Label Study2
Obsessive–compulsive disorder and the associated risk of autoimmune skin diseases: a nationwide population-based cohort study2
Digital CBT-I Treatment Improves Sleep and Reduces Anxiety and Depression Symptoms in Adults With Chronic Insomnia: Interim Analysis of DREAM Study2
The broad autism phenotype in real-life: clinical and functional correlates of autism spectrum symptoms and rumination among parents of patients with autism spectrum disorder – Corrigendum2
132 Treating Comorbid Childhood Bipolar Disorder and ADHD2
178 Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet Compared with Amphetamine Extended-Release Oral Suspension2
142 Withdrawal Symptom Assessment in an Esketamine Safety Study in Patients with Treatment-resistant Depression2
IVIG for Treatment-Resistant Psychosis For a Child with Turner Syndrome2
Benzodiazepines in autism spectrum disorder—wise or otherwise?2
AXS-05 (DEXTROMETHORPHAN-BUPROPION) Improves Depressive Symptoms and Functioning in Patients With One Prior Treatment Failure: Results From the Evolve Long-Term, Open Label Study2
Methylphenidate-Induced Chorea Due to Possible Cytochrome P450 Metabolism Heterogeneity - A Rare Case1
Neuropsychiatric phenotypes in functional movement disorder1
Long-Term Lumateperone Treatment in Bipolar Disorder: Six-Month Open-Label Extension Study1
Diagnostic Dilemma in Psychiatry: Disease of the Mind or the Media?1
120 Laryngeal Dystonia and Buccolingual Crisis: Dystonic Reactions in 2 Patients Receiving Prochlorperazine During Suboxone Therapy1
137 CME on Pharmacogenomics Testing Improves Knowledge, Competence, and Confidence Related to Implementing Testing in Practice1
COVID-19 Induced Psychosis in Patients with Underlying Mental Health Disorder: Case Report1
Careful, Women! Is Orgasm Worth the Cost of Your Cerebellum? Flibanserin-Induced Cerebellar Dysfunction1
Can Low Dose Sertraline Cause Serotonin Syndrome in Pediatric Patients? 2 Case Reports1
Standardized diagnostic assessment for child and adolescents mental health services: a leap forward in measurement-based care1
117 Impact of Antipsychotic Treatment Switching in Patients with Schizophrenia, Bipolar Disorder, and Major Depressive Disorder1
Hyperammonemia and First-Degree Atrio-Ventricular Block in Adult Male from Valproic Acid Toxicity1
151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study1
Characterization and Treatment Goals of Patients on Long-Acting Injectable vs Oral Antipsychotics: Results from a Patient/Caregiver/Psychiatrist Survey1
Othello Syndrome: Delusional Disorder - Jealous Type ≠ Violence1
Error-Related Brain Activity in ADHD: A Systematic Review and Meta-Analysis of Electroencephalography Markers of Cognitive Control Performance1
Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression1
Olanzapine/samidorphan combination consistently mitigates weight gain across various subgroups of patients1
Acute Emergence of Suicidal Thoughts Following Lemborexant Initiation: An Adverse Reaction Case Report1
A case study on attenuated forms of catatonic symptoms in schizophrenia: relevance of early intervention with electroconvulsive therapy1
Inflammation, cognitive dysfunction, and suicidal ideation among patients with major depression1
0.57619690895081